A new review brings together evidence that a type of immune cell called a macrophage can change into a myofibroblast, a cell that makes scar tissue. This process is called macrophage-to-myofibroblast transition, or MMT. The review reports that MMT has been seen in several organs, including the kidney, heart, lung, liver, and retina. This matters because scar tissue, also called fibrosis, can damage these organs over time.
The review is a summary of existing research, not a new experiment. It does not report how many people were studied, how long they were followed, or what treatments were tested. No side effects or safety concerns are described. The review also does not say whether MMT directly causes fibrosis or is simply a marker of it. That distinction is important and remains unclear.
Because the evidence is early and comes from a broad review, readers should not take this as proof that blocking MMT will treat or prevent disease. It is a promising area of research, but much more work is needed before any new treatment could be developed. For now, this finding helps scientists understand how fibrosis might happen, not how to stop it in patients.
Common questions
What is macrophage-to-myofibroblast transition (MMT)?
MMT is a process where a macrophage, a type of immune cell, changes into a myofibroblast, a cell that produces scar tissue. The review reports this has been seen in the kidney, heart, lung, liver, and retina. It is one way scientists think fibrosis may develop, but the exact role is still being studied.
Which organs are affected by MMT?
The review says MMT has been validated in multiple organs, including the kidney, heart, lung, liver, and retina. These are organs where fibrosis, or scarring, can cause serious problems. However, the review does not say how common MMT is or how much it contributes to disease in each organ.
Does this research mean there is a new treatment for fibrosis?
No. This is a review of existing evidence, not a clinical trial. It does not test any treatment or report patient outcomes. The finding helps explain a possible mechanism of fibrosis, but no new therapy is available based on this work. Any treatment decisions should be discussed with a doctor.
Is MMT proven to cause fibrosis?
The review does not establish cause and effect. It reports that MMT occurs and may participate in fibrogenesis, but it does not show that MMT directly causes fibrosis. More research is needed to understand whether targeting MMT could help prevent or treat scarring in people.
